Metabolic Research
Studied for its interaction with pathways governing energy expenditure and glucose regulation.
Overview
GLP3-R is a single-molecule peptide studied for its interaction with three distinct metabolic pathways: the GIP, GLP-1, and glucagon receptors. Where earlier generations of incretin-based compounds engaged one or two of these receptors, GLP3-R was designed to address all three within a single sequence, making it one of the most closely followed compounds in current metabolic research.
Suria's GLP3-R is synthesized to high purity and independently verified prior to release, giving researchers a consistent, well-documented starting point for pathway and body-composition studies.
Research Use Only. Not for human or veterinary use.
Specifications
Third-Party Testing
Available third-party analytical documentation for GLP3-R can be reviewed for applicable batches through Suria's Batch Documentation system. We believe documentation should be held to the same standard as the research it supports.
Certificates of Analysis will be available at time of launch.
Research Highlights
Studied for its interaction with pathways governing energy expenditure and glucose regulation.
A frequent focus of body-composition and weight-related research models.
Among the most actively studied triple-agonist compounds in current literature.
Engineered for extended systemic presence, supporting less frequent dosing protocols in study design.
Storage
Store at −20°C, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the recommended window for your protocol.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation